The PPAR agonist Rosiglitazone induces paracrine signaling in melanoma cells that activate stromal cells and enhances tumor growth.
Ontology highlight
ABSTRACT: The PPAR agonist Rosiglitazone induces paracrine signaling in melanoma cells that activate stromal cells and enhances tumor growth.
PROVIDER: PRJNA474184 | ENA |
REPOSITORIES: ENA
ACCESS DATA